Skip to main content
. Author manuscript; available in PMC: 2012 Mar 15.
Published in final edited form as: Int J Cancer. 2011 Mar 15;128(6):1393–1403. doi: 10.1002/ijc.25443

Figure 2.

Figure 2

Re-expression of genes (DCC, DLC1, PGP9.5, and KIF1A) after treatment with Aza in NPC cell lines. HNE and CNE cell lines were treated for 5 days with Aza at a 5μM concentration. Side controls are shown. GAPDH was used as a normalizing loading control.